Translational Nanobiology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892, USA.
Faculty of Medicine, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Flow Cytometry and Virometry Core Facility, Ottawa, Ontario, K1H 8M5, Canada.
Cytometry A. 2020 Jun;97(6):592-601. doi: 10.1002/cyto.a.24029. Epub 2020 Jun 1.
Flow cytometers have been utilized for the analysis of submicron-sized particles since the late 1970s. Initially, virus analyses preceded extracellular vesicle (EV), which began in the 1990s. Despite decades of documented use, the lack of standardization in data reporting has resulted in a growing body of literature that cannot be easily interpreted, validated, or reproduced. This has made it difficult for objective assessments of both assays and instruments, in-turn leading to significant hindrances in scientific progress, specifically in the study of EVs, where the phenotypic analysis of these submicron-sized vesicles is becoming common-place in every biomedical field. Methods for fluorescence and light scatter standardization are well established and the reagents to perform these analyses are commercially available. However, fluorescence and light scatter calibration are not widely adopted by the small particle community as methods to standardize flow cytometry (FCM) data. In this proof-of-concept study carried out as a resource for use at the CYTO2019 workshop, we demonstrate for the first-time simultaneous fluorescence and light scatter calibration of small particle data to show the ease and feasibility of this method for standardized FCM data reporting. This data was acquired using standard configuration commercial flow cytometers, with commercially available materials, published methods, and freely available software tools. We show that application of light scatter, fluorescence, and concentration calibration can result in highly concordant data between FCM platforms independent of instrument collection angle, gain/voltage settings, and flow rate; thus, providing a means of cross comparison in standard units. © 2020 International Society for Advancement of Cytometry.
流式细胞仪自 20 世纪 70 年代末以来就被用于亚微米颗粒的分析。最初,病毒分析先于细胞外囊泡(EV)分析,后者始于 20 世纪 90 年代。尽管已经有几十年的文献记载,但数据报告缺乏标准化,导致越来越多的文献难以解读、验证或复制。这使得对分析物和仪器的客观评估变得困难,反过来又严重阻碍了科学进步,特别是在 EV 研究中,对这些亚微米大小的囊泡的表型分析已成为每个生物医学领域的常见做法。荧光和光散射标准化方法已经成熟,执行这些分析的试剂也可商购。然而,荧光和光散射校准并没有被小颗粒社区广泛采用,作为流式细胞仪(FCM)数据标准化的方法。在这项作为 CYTO2019 研讨会使用资源进行的概念验证研究中,我们首次展示了同时对小颗粒数据进行荧光和光散射校准,以展示这种方法用于标准化 FCM 数据报告的简便性和可行性。这些数据是使用标准配置的商用流式细胞仪,使用市售材料、已发表的方法和免费提供的软件工具获得的。我们表明,应用光散射、荧光和浓度校准可以在不依赖仪器采集角度、增益/电压设置和流速的情况下,在 FCM 平台之间产生高度一致的数据;因此,提供了一种以标准单位进行交叉比较的方法。